weight-loss drugs
Scope
Date
~
-
Alternative investments
S.Korea's DLS incurring losses due to stock slump exceed $800 billion
South Korea's derivatives-linked securities that entered the knock-in or loss period due to stock slumps at home and abroad exceeded 1 trillion won ...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
Airlines
Korean LCCs cancel China-bound flights due to COVID-19
Toughened COVID-19 testing requirements on Chinese travelers will likely dent hopes for South Korea's low-cost airlines to recover from three years ...
Jan 04, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB confirms ophthalmic disease treatment in phase 3 clinical trials
South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...
Jan 03, 2023 (Gmt+09:00)
-
Private equity
Korean banks must increase total shareholder returns: Align Partners
South Korean private equity firm Align Partners Capital Management Inc. is set to lead shareholder activism against the country’s top financia...
Jan 02, 2023 (Gmt+09:00)
-
Pension funds
Korea’s NPS to be in red in 2022 with 5.3% loss in Jan-Oct
South Korea’s National Pension Service (NPS), the world’s third-largest such fund, is poised to report an annual loss in 2022 for the fi...
Jan 01, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Bio & Pharma
KOICA donates Celltrion's Herzuma to Ukraine
Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
CJ applies to FDA for trials of immuno-anticancer drug candidate
CJ Bioscience, an independent red bio (pharmaceutical and healthcare) subsidiary of CJ CheilJedang Corp., said on Monday it has submitted a phase 1 ...
Dec 26, 2022 (Gmt+09:00)
-
Bio & Pharma
LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn
South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
Dong-A ST incorporates NeuroBo as subsidiary
Dong-A ST said on Friday that it would acquire American drug company NeuroBo Pharmaceuticals as a subsidiary.NeuroBo, located in Boston, is a Nasdaq...
Dec 23, 2022 (Gmt+09:00)
-
Electronics
LG Innotek to unveil precision smartphone camera module
South Korea's LG Innotek said on Thursday it will unveil its high-magnification optical camera module with continuous zoom next month at CES 2023, t...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean biopharmaceutical sector to see brisk M&As in H1, 2023
An expert says the first half of next year will see the start of brisk M&As in biopharmaceuticals targeting strategic investors.Pyeon Jae-seong,...
Dec 21, 2022 (Gmt+09:00)
-
Artificial intelligence
Syntekabio launches new drug development platform STB Cloud in US
Syntekabio,Inc., a South Korean artificial intelligence (AI) drug development company, said on Monday it has launched its cloud-based AI drug develo...
Dec 19, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem in $95.5 million drug out-licensing deal with China’s Innovent
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., and China’s biotech company Innovent Biologics have entered into a strategi...
Dec 15, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries
South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem confirms diabetes drug Zemidapa's efficacy in phase 3 trials
LG Chem Ltd. announced in a disclosure on Monday that it had confirmed superior efficacy in phase 3 clinical trials for the combined administration ...
Dec 13, 2022 (Gmt+09:00)
-
Bio & Pharma
New drug developer Onconic Therapeutics raises $20 mn in Series B
South Korean drug developer Onconic Therapeutics, announced on Friday that it raised 26 billion won ($19.9 million) in Series B funding, with cumula...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals launches epilepsy drug in France
South Korean SK Biopharmaceuticals Co. said on Friday that its treatment of epilepsy "Cenobamate" has been approved for sale in France.The company l...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea approves Daewoong Pharmaceutical's diabetes drug
DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...
Dec 02, 2022 (Gmt+09:00)
-
Supply chain
Korea’s industrial losses balloon to $1.2 bn as truckers continue strike
South Korea’s manufacturing sector faces ballooning losses across industries as the trucker strike entered its eighth day on Thursday, disrupt...
Dec 01, 2022 (Gmt+09:00)
-
Pension funds
NPS posts 7% investment loss in Q1-Q3 as equities, bonds plunge
National Pension Service (NPS) of South Korea said Tuesday it saw a cumulative loss of 7.1% on investment, or 68 trillion won ($51.3 billion), betwe...
Nov 29, 2022 (Gmt+09:00)
-
Korean startups
Sandbox Network pursues corporate restructuring to dig out of red
Sandbox Network, Inc. announced on Sunday that it will go through corporate restructuring and encourage employees to voluntarily resign, hit by cont...
Nov 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Mezzion Pharma to try again for US FDA approval of drug
South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...
Nov 23, 2022 (Gmt+09:00)
-
Foreign exchange
Korean exporters suffer FX derivate losses on weak won
More South Korean exporters suffered massive losses from foreign exchange derivatives on a weaker won, failing to benefit from the unit’s depr...
Nov 17, 2022 (Gmt+09:00)
-
Earnings
KEPCO to see record loss 2022 on slower power tariff hikes
Korea Electric Power Corp. (KEPCO), the state-run utility, is set to suffer a record operating loss this year with a shortfall mounting to the secon...
Nov 11, 2022 (Gmt+09:00)
-
Investment banking
Korean brokerages' restructuring targets investment banking units
South Korea’s small- and mid-sized brokerage houses have begun their workforce reductions ahead of the end of the year. The brokerages are set...
Nov 10, 2022 (Gmt+09:00)
-
Korean food
Want to improve memory? Eat more ginseng
Consumption of ginseng and red ginseng (hongsam) can improve memory capacity and prevent high blood pressure, diabetes and muscle loss, according to...
Nov 02, 2022 (Gmt+09:00)